tradingkey.logo
搜尋

Labcorp Holdings Inc

LH
添加自選
322.980USD
-1.880-0.58%
交易中 09/09, 09:44美東
26.13B總市值
28.42本益比TTM

關於 Labcorp Holdings Inc 公司

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Labcorp Holdings Inc 簡介

公司代碼LH
公司名稱Labcorp Holdings Inc
上市日期Apr 24, 1991
CEOSchechter (Adam H)
員工數量70000
證券類型Ordinary Share
年結日Apr 24
公司地址358 S Main St
城市BURLINGTON
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編27215
電話13362291127
網址https://www.labcorp.com/
公司代碼LH
上市日期Apr 24, 1991
CEOSchechter (Adam H)

Labcorp Holdings Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
102.56K
-4.55%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
13.74K
--
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
6.96K
-13.29%
Ms. Kerrii B. Anderson
Ms. Kerrii B. Anderson
Independent Director
Independent Director
6.85K
-43.79%
Mr. Bryan T. Vaughn
Mr. Bryan T. Vaughn
Executive Vice President - Diagnostics
Executive Vice President - Diagnostics
6.75K
--
Ms. Sandra Dillard van Der Vaart
Ms. Sandra Dillard van Der Vaart
Executive Vice President, Chief Legal Officer, and Corporate Secretary
Executive Vice President, Chief Legal Officer, and Corporate Secretary
5.82K
+62.94%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
102.56K
-4.55%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
13.74K
--

常見問題

Labcorp Holdings Inc的前五大股東是誰?

Labcorp Holdings Inc的前五大股東如下:Mr. Adam H. Schechter

有多少機構持有Labcorp Holdings Inc(LH)的股份?

截至2026Q1,共有1855家機構持有Labcorp Holdings Inc的股份,合計持有的股份價值約為88.74M,占公司總股份的108.22% 。與2025Q4相比,機構持股有所增加,增幅為5570263.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有